JADPRO Live Certified Educational Activities

Earn continuing education (CE) credit with these certified educational activities based on presentations from recent JADPRO Live at APSHO conferences. Access the full-length video presentation, the slide deck, transcript, and the entire lecture as a podcast. You can earn CE for each of these activities by following the links.

Click on any of the video presentations below to get started!

All  |  CAR T-Cell Therapy  |  Indolent Lymphomas  |  Prostate Cancer  |  Hodgkin Lymphoma  |  Myeloid Malignancies  |  Ovarian Cancer  |  Drug Updates - Heme  |  DDx Hematologic  |  Plasma Cell Dyscrasias  |  Thoracic Cancer  |  Drug Updates - Solid  |  Melanoma  |  VTE Prevention  |  RCC  |  Palliative Care  |  Mary Pazdur Award
New Drug Updates in Hematologic Malignancies

This activity is supported by educational grants from AbbVie Inc., Acerta Pharma, a member of the AstraZeneca Group, and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

New Drug Updates in Hematologic Malignancies

Discover the latest pharmacology and indication approvals for the management of patients with hematologic malignancies, including pivotal clinical trial data, associated signs and symptoms of serious or life-threatening adverse effects, and the impact of these agents in advanced practice.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.



Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.